News
Warwick Evidence are tendering for a Systematic Reviewer
The tender is now live and will close on 7th January 2013 at 12 Midday.
Documents can be requested and downloaded from the following address –
https://in-tendhost.co.uk/universityofwarwick
Please note, as the process is now live no direct contact should be made with Warwick Evidence in respect of this tender. All queries must be directed via In-Tend.
Dr Paul Sutcliffe, in collaboration with the universities of Nottingham and Sheffield, have been awarded a grant by the NIHR
Dr Paul Sutcliffe has been awarded (co-applicant) in collaboration with researchers at the universities of Nottingham and Sheffield a grant by the NIHR for their project entitled "An evidence synthesis, meta-analysis and decision analytic modelling following a systematic review of quantitative and qualitative studies evaluating the effectiveness, cost-effectiveness, safety and acceptability of interventions to prevent PND". The main objectives of the project are to determine the clinical effectiveness of antenatal interventions and postnatal interventions for preventing PND, to provide a detailed service user and service provider perspective on the uptake, acceptability, and potential harms of antenatal and postnatal interventions, to undertake a meta-analysis of available evidence, to undertake an economic analysis, to identify moderators and mediators of the efficacy of preventive interventions and to determine the potential value of collecting further data on all or some of the input parameters.
New job advertised for a Research Fellow Systematic Reviewer (Maternity Cover)
Warwick Evidence are advertising for a Research Fellow Systematic Reviewer (Maternity Cover). The closing date for all applications is midnight on the 12th November and applications can be made online by following the below link:
https://secure.admin.warwick.ac.uk/webjobs/jobs/research/job27778.html
Professor Norman Waugh and Rachel Court new publication accepted.
Professor Norman Waugh and Rachel Court new publication accepted entitled "Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes"